Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 16:18:571-578.
doi: 10.2147/TCRM.S361791. eCollection 2022.

The Changes of Thyroid Function and Related Factors in Critical Patients without Thyroid Illness in ICU: A Retrospective Cross-Sectional Study

Affiliations

The Changes of Thyroid Function and Related Factors in Critical Patients without Thyroid Illness in ICU: A Retrospective Cross-Sectional Study

Jiang-Nan Zhang et al. Ther Clin Risk Manag. .

Abstract

Objective: To retrospectively analyze the changes of thyroid function and related factors in critical patients with non-thyroid illness, hoping to find some indicators for the further examination of the thyroid function in the intensive care unit situation.

Methods: The clinical data of 52 patients admitted to the ICU of Fuzhou First Hospital in Fujian Province, China, from May 2018 to March 2019 were collected. Patients were allocated into the central hypothyroidism group (CH group, n = 21) and the low T3 syndrome group (LT3S group, n = 31) based on thyroid function. All related medical data were collected, and the correlations between variables were identified using Spearman's or Pearson's rank correlation coefficients.

Results: The Acute Physiology and Chronic Health Evaluation (APACHE) II score in the CH group and the LT3S group were 20.6 ± 3.6 and 19.3 ± 3.6, respectively, measured within 24 hours following hospital admission. The mean value of thyroid-stimulating hormone (TSH) in the CH group (0.3 ± 0.3 IU/mL) was significantly lower than that in the LT3S group (1.7 ± 0.9 IU/mL), P < 0.001. Fasting plasma glucose (FPG) level in the CH group was significantly higher than that in the LT3S group (10.3 ± 5.0 mmol/L vs 6.8 ± 2.5 mmol/L, P = 0.002).

Conclusion: Central hypothyroidism may exist in critically ill patients and may be associated with elevated fasting plasma glucose levels; accordingly, it should be included as part of patient assessment. When FPG is higher than 6.4mmol/L on admission, thyroid function should be actively examined.

Keywords: central hypothyroidism; critical illness; fasting blood glucose; thyroid-stimulating hormone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest in this work.

Figures

Figure 1
Figure 1
(A) Fasting blood plasma glucose level was negatively correlated with serum thyroid-stimulating hormone level; (B) fasting blood plasma glucose level was negatively correlated with serum reverse triiodothyronine level; (C) fasting blood plasma glucose level was not associated with serum free triiodothyronine level; (D) fasting blood glucose level was not associated with serum free tetraiodothyronine level.
Figure 2
Figure 2
With fasting plasma glucose as the variable and central hypothyroidism as the grouped variable, the receiver operating characteristic curve was created and the area under the curve was calculated as being 0.78.

Similar articles

Cited by

References

    1. Berk J, Wade R, Baser HD, Lado J. Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome. BMC Cardiovasc Disord. 2015;15:123. doi:10.1186/s12872-015-0112-3 - DOI - PMC - PubMed
    1. Drechsler C, Schneider A, Gutjahr-Lengsfeld L, et al. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis. 2014;63(6):988–996. doi:10.1053/j.ajkd.2013.10.009 - DOI - PubMed
    1. Kanji S, Neilipovitz J, Neilipovitz B, et al. Triiodothyronine replacement in critically ill adults with non-thyroidal illness syndrome. Can J Anaesth. 2018;65(10):1147–1153. doi:10.1007/s12630-018-1177-0 - DOI - PubMed
    1. De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006;22(1):57–86. doi:10.1016/j.ccc.2005.10.001 - DOI - PubMed
    1. Chopra IJ. Nonthyroidal illness syndrome or euthyroid sick syndrome? Endocr Pract. 1996;2(1):45–52. - PubMed